Clinical Trials on Opioid Dependence in New Zealand

Total 612 results

Yale University
National Institute on Drug Abuse (NIDA)

Completed

Disulfiram for Cocaine Abuse in Buprenorphine Treatment

Opioid Dependency | Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Chronic Pain and Opioid Dependence Assessment and Treatment (CPODAT)

Chronic Pain | Opioid Dependency

United States
National Development and Research Institutes, Inc.

Unknown

Applying Web Technology to Buprenorphine Treatment

Adult Opioid-Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Nalrexone Facilitated Discontinuation of Buprenorphine

Stable Opioid Dependence

United States
National Development and Research Institutes, Inc.
St. Luke's-Roosevelt Hospital Center

Unknown

Science-Based Treatment for Opioid-Dependent Adolescents

Opioid-Dependence Among Adolescents

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Aprepitant Effects in Intravenous Heroin Dependence

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NAMHS)

Heroin Dependence | Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients

Benzodiazepine Dependence | Opioid Dependence

United States
Juul Labs, Inc.

Completed

Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
Juul Labs, Inc.

Completed

Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
Yale University

Withdrawn

Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol).

Drug Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

Substance-Related Disorders | Opioid Dependence

United States
NYU Langone Health

Completed

A Pragmatic Trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Model for Engaging Patients in Opioid Use Disorder Treatment (CATCH)

Opioid Dependence | Opioid Abuse

United States
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

FMRI of Stress and Addictive Disorders

Alcoholism | Opioid Dependence | Cocaine Dependence | Adolescents | Pathological Gamblers

United States
Orexo AB
Worldwide Clinical Trials

Completed

Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence

Opioid Dependence, on Agonist Therapy

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Medication-Assisted Treatment for Youth With Substance Use Disorders

Opioid Use Disorder | Opioid Dependence

United States
NYU Langone Health

Withdrawn

Needle-X: Usability Testing of a Smartphone Application

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Dronabinol Naltrexone Treatment for Opioid Dependence (Domino)

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Improved Strategies for Outpatient Opioid Detoxification

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Facilitating Rapid Naltrexone Initiation

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine and Naltrexone Treatment for Opioid Dependence (NAMHS-1)

Opioid Dependence

United States
New York State Psychiatric Institute

Completed

Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse (PAIN)

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); MediciNova

Completed

Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers

Opioid Dependence | Opioid Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

Heroin Dependence

United States
Rutgers, The State University of New Jersey
National Institute on Drug Abuse (NIDA)

Completed

Developing a Smoking Cessation Intervention for Methadone Maintained Smokers

Nicotine Dependence | Opiate Dependence

United States
Orexo AB
Worldwide Clinical Trials

Completed

Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults (ISTART)

Opioid Dependence, on Agonist Therapy

United States
NYU Langone Health
NYC Health + Hospitals

Completed

XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
Yale University

Completed

A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence

Opioid Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

Substance-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence

Opiate Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Omeros Corporation

Terminated

Pioglitazone for Heroin and for Nicotine Dependence

Heroin Dependence | Nicotine Dependence

United States
Weill Medical College of Cornell University
The Institute for Family Health; New York State Health Foundation

Completed

Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients

Opioid-Related Disorders | Opioid Use | Opioid Abuse | Prescription Drug Abuse and Dependency

United States
Yale University

Completed

Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET

Cocaine Dependence | Opiate Dependence

United States
University of Auckland, New Zealand

Withdrawn

Improving Pain Relief Following Laparoscopic Ventral Hernia Repair

Pain, Postoperative | Anesthesia, Local | Hernia, Ventral | Complications | Laparoscopy | Analgesics, Opioid

New Zealand
University of Connecticut
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users

HIV | Opioid Dependence

United States
Hurd,Yasmin, Ph.D.
Jazz Pharmaceuticals

Recruiting

Neuroimaging and CBD for Opiod Use Disorder

Substance-Related Disorders | Opioid-Related Disorders | Opioid Use Disorder | Heroin Abuse

United States
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); The City University of New York; Washington...

Completed

Pilot Test of a Community-based Buprenorphine Treatment Intervention

Opioid Dependence | Injection Drug Use

United States
The University of New South Wales

Unknown

Community Studies of Long Acting Buprenorphine (CoLAB) (CoLAB)

Opioid Dependence

Australia
Indivior Inc.

Completed

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Opioid Dependence | Opioid Related Disorders

United States
NYU Langone Health
Wright State University

Completed

Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments

Opioid Dependence

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Starting Treatment With Agonist Replacement Therapies Follow-up Study

Opioid Dependence

United States
BioDelivery Sciences International

Completed

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects

Opioid Dependence

United States
University of California, Los Angeles

Completed

Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

Heroin Dependence | Substance Withdrawal Syndrome | Morphine Dependence

United States
University of Pennsylvania
Patient-Centered Outcomes Research Institute

Completed

The Life STORRIED Study

Risk Behavior | Communication | Opioid Dependence | Narrative Medicine

United States
Hudson Medical
Ethos Research & Development

Enrolling by invitation

The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients

Opioid Dependence | Opioid Use | Pain, Chronic | Inflammation Chronic

United States
Alkermes, Inc.

Completed

ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry (VICTORY)

Opioid Dependence

United States
NYU Langone Health
National Institutes of Health (NIH)

Recruiting

ED Observation for Opioid Use Disorder

Opiod Use Disorder

United States

Clinical Trials on Opioid Dependence in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations